Bank Julius Baer & Co. Ltd, Zurich 10x Genomics, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$55.7 - $145.79 $5,570 - $14,579	-100 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$145.58 - $192.14 $915,552 - $1.21 Million	-6,289 Reduced 98.43%	100 $15,000
Q2 2021 Jul 23, 2021	SELL	$134.22 - $202.37 $4.88 Million - $7.36 Million	-36,382 Reduced 85.06%	6,389 $1.25 Million
Q1 2021 May 10, 2021	SELL	$140.25 - $196.86 $410,652 - $576,406	-2,928 Reduced 6.41%	42,771 $7.74 Million
Q4 2020 Feb 24, 2021	SELL	$126.47 - $163.7 $3.04 Million - $3.94 Million	-24,076 Reduced 34.51%	45,699 $6.47 Million
Q4 2020 Feb 12, 2021	BUY	$126.47 - $163.7 $5.5 Million - $7.12 Million	43,524 Added 165.8%	69,775 $6.47 Million
Q3 2020 Nov 10, 2020	BUY	$87.44 - $125.0 $2.3 Million - $3.28 Million	26,251 New	26,251 $3.27 Million

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.